Protein epitope mimetics as anti-infectives

Current Opinion in Chemical Biology

Volumn 15, Issue 3, 2011, Pages 379-386

  Robinson, John A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATIONIC ANTIMICROBIAL PEPTIDE DERIVATIVE; EPITOPE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN EPITOPE MIMETIC; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BIOMIMETICS; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SURFACE PROPERTY; VIRUS INFECTION;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOMIMETICS; DRUG DESIGN; EPITOPES; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; PROTEINS;

EID: 79957979922     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2011.02.015     Document Type: Review

References (90)

1. Robinson J.A. β-Hairpin peptidomimetics: design, structures and biological activities. Acc Chem Res 2008, 41:1278-1288.
2. Ross N.T., Katt W.P., Hamilton A.D. Synthetic mimetics or protein secondary structure domains. Philos Trans R Soc A 2010, 368:989-1008.
3. Henchey L.K., Jochim A.L., Arora P.S. Contemporary strategies for the stabilization of peptides in the α-helical conformation. Curr Opin Chem Biol 2008, 12:692-697.
4. Graner J., Harding M.M. Design and synthesis of α-helical peptides and mimetics. Org Biomol Chem 2007, 5:3577-3585.
5. Nowick J.S. Exploring β-sheet structure and interactions with chemical model systems. Acc Chem Res 2008, 41:1319-1330.
6. Eichler J. Peptides as protein binding site mimetics. Curr Opin Chem Biol 2008, 12:707-713.
7. Goodman C.M., Choi S., Shandler S., DeGrado W.F. Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol 2007, 3:252-262.
8. Horne W.S., Gellman S.H. Foldamers with heterogeneous backbones. Acc Chem Res 2008, 41:1399-1408.
9. Wells J.A., McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450:1001-1009.
10. Reichmann D., Rahat O., Cohen M., Neuvirth H., Schreiber G. The molecular architecture of protein-protein binding sites. Curr Opin Struct Biol 2007, 17:67-76.
11. Editorial: Urgently needed: new antibiotics. The Lancet 2009, 374:1868.
12. Taubes G. The bacteria fight back. Science 2008, 321:356-361.
13. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., Scheld M., Spellberg B., Bartlett J. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1-12.
14. Gilbert D.N., Guidos R.J., Boucher H.W., Talbot G.H., Spellberg B., Edwards J.E., Scheld W.M., Bradley J.S., Bartlett J.G. The 10x'20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis 2010, 50:1081-1083.
15. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
16. Bumann D. Has nature already identified all useful antibacterial targets. Curr Opin Microbiol 2008, 11:387.
17. Falconer S.B., Brown E.D. New screens and targets in antibacterial drug discovery. Curr Opin Microbiol 2009, 12:497-504.
18. Hancock R.E.W., Sahl H.-G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006, 24:1551-1557.
19. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol 2005, 3:238-250.
20. Lai Y., Gallo R.L. AMPed up immunity: how antimicobial peptides have multiple roles in immune defense. Trends Immunol 2009, 30:131-141.
21. Brown K.L., Hancock R.E.W. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006, 18:24-30.
22. Silhavy T.J., Kahne D., Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2010, 2:16.
23. Melo M.N., Ferre R., Castanho M.A.R.B. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Microbiol 2009, 7:245-250.
24. Wu M., Maier E., Benz R., Hancock R.E.W. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999, 38:7235-7242.
25. Ryu D.H., Litovchick A., Rando R.R. Stereospecificity of aminoglycoside-ribosomal interactions. Biochemistry 2002, 41:10499-10509.
26. Silva J.G., Carvalho I. New insights into aminoglycoside antibiotics and derivatives. Curr Med Chem 2007, 14:1101.
27. Nicolas P. Multifunctional host defense peptides: intracellular-targeting antimicrobial peptides. FEBS J 2009, 276:6483-6496.
28. Auvynet C., Rosenstein Y. Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 2009, 276:6497-6508.
29. Strominger J.L. Animal antimicrobial peptides: ancient players in innate immunity. J Immunol 2009, 182:6633-6634.
30. Wieczorek M., Jenssen H., Kindrachuk J., Scott W.R.P., Elliott M., Hilpert K., Cheng J.T.J., Hancock R.E.W., Straus S.K. Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol 2010, 17:970-980.
31. Scott M.G., Dullaghan E., Mookherjee N., Glavas N., Waldbrook M., Thompson A., Wang A., Lee K., Doria S., Hamill P., et al. An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 2007, 25:465-472.
32. Giuliani A., Pirri G., Nicoletto S. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2007, 2:1-33.
33. Cherkasov A., Hilpert K., Jenssen H., Fjell C.D., Waldbrook M., Mullaly S.C., Volkmer R., Hancock R.E.W. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 2009, 4:65-74.
34. Easton D.M., Nijnik A., Mayer M.L., Hancock R.E.W. Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 2009, 27:582-590.
35. Fjell C.D., Jenssen H., Hilpert K., Cheung W.A., Pante N., Hancock R.E.W., Cherkasov A. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem 2009, 52:2006-2015.
36. Hilpert K., Elliott M., Jenssen H., Kindrachuk J., Fjell C.D., Korner J., Winkler D.F.H., Weaver L.L., Henklein P., Ulrich A.S., et al. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 2009, 16:58-69.
37. Nolan E.M., Walsh C.T. How nature morphs peptide scaffolds into antibiotics. ChemBioChem 2009, 10:34-53.
38. Vaara M. New approaches in peptide antibiotics. Curr Opin Pharmacol 2009, 9:571-576.
39. Giuliani A., Pirri G., Bozzi A., Di Giulio A., Aschi M., Rinaldi A.C. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell Mol Life Sci 2008, 65:2450-2460.
40. Vooturi S.K., Firestine S.M. Synthetic membrane-targeted antibiotics. Curr Med Chem 2010, 17:2292-2300.
41. Robinson J.A., Shankaramma S.C., Jettera P., Kienzl U., Schwendener R.A., Vrijbloed J.W., Obrecht D. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin I. Bioorg Med Chem 2005, 13:2055-2064.
42. Shankaramma S.C., Athanassiou Z., Zerbe O., Moehle K., Mouton C., Bernardini F., Wrijbloed J.W., Obrecht D., Robinson J.A. Macrocyclic hairpin mimetics of the cationic antimicrobial peptide protegrin I: a new family of broad-spectrum antibiotics. ChemBioChem 2002, 3:1126-1133.
43. Shankaramma S.C., Moehle K., James S., Vrijbloed J.W., Obrecht D., Robinson J.A. A family of macrocyclic antibiotics with a mixed peptide-peptoid β-hairpin backbone conformation. Chem Commun 2003, 1842-1843.
44. Srinivas N., Jetter P., Ueberbacher B.J., Werneburg M., Zerbe K., Steinmann J., Van der Meijden B., Bernardini F., Lederer A., Dias R.L.A., et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 2010, 327:1010-1013.
45. Arvidsson P.I., Ryder N.S., Weiss H.M., Gross G., Kretz O., Woessner R., Seebach D. Antibiotic and hemolytic activity of a β2/β3 peptide capable of folding into a 12/10-helical secondary structure. ChemBioChem 2003, 4:1345-1347.
46. Epand R.F., Raguse L., Gellman S.H., Epand R.M. Antimicrobial 14-helical β-peptides: potent bilayer disrupting agents. Biochemistry 2004, 43:9527-9535.
47. Hamuro Y., Schneider J.P., DeGrado W.F. De novo design of antibacterial β-peptides. J Am Chem Soc 1999, 121:12200-12201.
48. Liu D., DeGrado W.F. De novo design, synthesis, and characterization of antimicrobial β-peptides. J Am Chem Soc 2001, 123:7553-7559.
49. Porter E.A., Wang X., Lee H.-S., Weisblum B., Gellman S.H. Non-haemolytic β-amino-acid oligomers. Nature 2000, 404:565.
50. Porter E.A., Weisblum B., Gellman S.H. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial β-peptides. J Am Chem Soc 2002, 124:7324-7330.
51. Porter E.A., Weisblum B., Gellman S.H. Use of parallel synthesis to probe structure-activity relationships among 12-helical β-peptides: evidence of a limit on antimicrobial activity. J Am Chem Soc 2005, 127:11516-11529.
52. Raguse T.L., Porter E.A., Weisblum B., Gellman S.H. Structure-activity studies of 14-helical antimicrobial β-peptides: probing the relationship between conformational stability and antimicrobial potency. J Am Chem Soc 2002, 124:12774-12785.
53. Schmitt M.A., Weisblum B., Gellman S.H. Unexpected relationships between structure and function in α,β-peptides: antimicrobial foldamers with heterogeneous backbones. J Am Chem Soc 2004, 126:6848-6849.
54. Schmitt M.A., Weisblum B., Gellman S.H. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of α/β-peptides. J Am Chem Soc 2006, 129:417-428.
55. Ng S., Goodson B., Ehrhardt A., Moos W.H., Siani M., Winter J. Combinatorial discovery process yields antimicrobial peptoids. Bioorg Med Chem 1999, 7:1781-1785.
56. Patch J.A., Barron A.E. Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 2003, 125:12092-12093.
57. Chongsiriwatana N.P., Patch J.A., Czyzewski A.M., Dohm M.T., Ivankin A., Gidalevitz D., Zuckermann R.N., Barron A.E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci U S A 2008, 105:2794-2799.
58. Olsen C.A., Ziegler H.L., Nielsen H.M., Frimodt-Møller N., Jaroszewski J.W., Franzyk H. Antimicrobial, hemolytic, and cytotoxic activities of β-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs. ChemBioChem 2010, 11:1356-1360.
59. Gobbo M., Benincasa M., Bertoloni G., Biondi B., Dosselli R., Papini E., Reddi E., Rocchi R., Tavano R., Gennaro R. Substitution of the arginine/leucine residues in apidaecin Ib with peptoid residues: effect on antimicrobial activity, cellular uptake, and proteolytic degradation. J Med Chem 2009, 52:5197-5206.
60. Scott R.W., DeGrado W.F., Tew G.N. De novo designed synthetic mimics of antimicrobial peptides. Curr Opin Biotechnol 2008, 19:620-627.
61. Choi S., Isaacs A., Clements D., Liu D.H., Kim H., Scott R.W., Winkler J.D., DeGrado W.F. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc Natl Acad Sci U S A 2009, 106:6968-6973.
62. Gabriel G.J., Tew G.N. Conformationally rigid proteomimetics: a case study in designing antimicrobial aryl oligomers. Org Biomol Chem 2008, 6:417-423.
63. Liu D.H., Choi S., Chen B., Doerksen R.J., Clements D.J., Winkler J.D., Klein M.L., DeGrado W.F. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew Chem Int Ed 2004, 43:1158-1162.
64. Radzishevsky I.S., Rotem S., Bourdetsky D., NavonVenezia S., Carmeli Y., Mor A. Improved antimicrobial peptides based on acyl-lysine oligomers. Nat Biotechnol 2007, 25:657-659.
65. Kuroda K., DeGrado W.F. Amphiphilic polymethacrylate derivatives as antimicrobial agents. J Am Chem Soc 2005, 127:4128-4129.
66. Tew G.N., Scott R.W., Klein M.L., DeGrado W.F. De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res 2010, 43:30-39.
67. Mowery B.P., Lee S.E., Kissounko D.A., Epand R.F., Epand R.M., Weisblum B., Stahl S.S., Gellman S.H. Mimicry of antimicrobial host-defense peptides by random copolymers. J Am Chem Soc 2007, 129:15474-15476.
68. Claudon P., Violette A., Lamour K., Decossas M., Fournel S., Heurtault B., Godet J., Mély Y., Jamart-Grégoire B., Averlant-Petit M.-C., et al. Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone. Angew Chem Int Ed 2010, 49:333-336.
69. Gabriel G.J., Madkour A.E., Dabkowski J.M., Nelson C.F., Nusslein K., Tew G.N. Synthetic mimic of antimicrobial peptide with nonmembrane-disrupting antibacterial properties. Biomacromolecules 2008, 9:2980-2983.
70. Lienkamp K., Tew G.N. Synthetic mimics of antimicrobial peptides-a versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cell-penetrating polymers. Chem Eur J 2009, 15:11784-11800.
71. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J., Klein M.L., DeGrado W.F. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A 2002, 99:5110-5114.
72. Bremner J.B., Keller P.A., Pyne S.G., Boyle T.P., Brkic Z., David D.M., Garas A., Morgan J., Robertson M., Somphol K., et al. Binaphthyl-based dicationic peptoids with therapeutic potential. Angew Chem Int Ed 2010, 49:537-540.
73. Bremner J.B., Keller P.A., Pyne S.G., Boyle T.P., Brkic Z., Morgan J., Somphol K., Coates J.A., Deadman J., Rhodes D.I. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2. Bioorg Med Chem 2010, 18:4793-4800.
74. Friedrich C.L., Moyles D., Beveridge T.J., Hancock R.E.W. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother 2000, 44:2086-2092.
75. Zhang L., Dhillon P., Yan H., Farmer S., Hancock R.E.W. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2000, 44:3317-3321.
76. Bolintineanu D., Hazrati E., Davis H.T., Lehrer R.I., Kaznessis Y.N. Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides 2010, 31:1-8.
77. Ruiz N., Kahne D., Silhavy T.J. Transport of lipopolysaccharide across the cell envelope: the long road of discovery. Nat Rev Microbiol 2009, 7:677-683.
78. Sperandeo P., Dehó G., Polissi A. The lipopolysaccharide transport system of Gram-negative bacteria. Biochim Biophys Acta 2009, 1791:594-602.
79. Chng S.-S., Ruiz N., Chimalakonda G., Silhavy T.J., Kahne D. Characterization of the two-protein complex in Escherichia coli responsible for lipopolysaccharide assembly at the outer membrane. Proc Natl Acad Sci U S A 2010, 107:5363-5368.
80. Chng S.S., Gronenberg L.S., Kahne D. Proteins required for lipopolysaccharide assembly in Escherichia coli form a transenvelope complex. Biochemistry 2010, 49:4565-4567.
81. Cascales E., Buchanan S.K., Duche D., Kleanthous C., Lloubes R., Postle K., Riley M., Slatin S., Cavard D. Colicin biology. Microbiol Mol Biol Rev 2007, 71:158-229.
82. Housden N.G., Wojdyla J.A., Korczynska J., Grishkovskaya I., Kirkpatrick N., Brzozowski A.M., Kleanthous C. Directed epitope delivery across the Escherichia coli outer membrane through the porin OmpF. Proc Natl Acad Sci U S A 2010, 107:21412-21417.
83. Walther D.M., Rapaport D., Tommassen J. Biogenesis of β-barrel membrane proteins in bacteria and eukaryotes: evolutionary conservation and divergence. Cell Mol Life Sci 2009, 66:2789-2804.
84. DeMarco S.J., Henze H., Lederer A., Moehle K., Mukherjee R., Romagnoli B., Robinson J.A., Brianza F., Gombert F.O., Lociuro S., et al. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles. Bioorg Med Chem 2006, 14:8396-8404.
85. Moncunill G., Armand-Ugón M., Clotet-Codina I., Pauls E., Ballana E., Llano A., Romagnoli B., Vrijbloed J.W., Gombert F.O., Clotet B., et al. Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026. Mol Pharmacol 2008, 73:1264-1273.
86. Tamamura H., Tsutsumi H., Masuno H., Fujii N. Development of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Curr Med Chem 2007, 14:93-102.
87. Ueda S., Oishi S., Wang Z.X., Araki T., Tamamura H., Cluzeau J., Ohno H., Kusano S., Nakashima H., Trent J.O., et al. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities. J Med Chem 2007, 50:192-198.
88. Tamamura H., Araki T., Ueda S., Wang Z.X., Oishi S., Esaka A., Trent J.O., Nakashima H., Yamamoto N., Peiper S.C., et al. Identification of novel low molecular weight CXCR4 antagonists by structural tuning of cyclic tetrapeptide scaffolds. J Med Chem 2005, 48:3280-3289.
89. Wu B.L., Chien E.Y.T., Mol C.D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F.C., et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330:1066-1071.
90. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF chimera-a visualization system for exploratory research and analysis. J Comp Chem 2004, 25:1605-1612.